SCHEMBL741750

SCHEMBL741750

N#CC1=C(N)OC2=C(C(=O)CC(c3ccccc3)C2)C1c1cccc(OCc2c(F)cccc2Cl)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.71
KMT2A Q03164 6/20 0.71
MEN1 O00255 5/20 0.71
MAPT P10636 4/20 0.71
HTT P42858 2/20 0.71
CYP1A2 P05177 1/20 0.71
CYP3A4 P08684 1/20 0.71
CYP2C9 P11712 1/20 0.71
CYP2C19 P33261 1/20 0.71
RECQL P46063 1/20 0.71
NPSR1 Q6W5P4 1/20 0.71
GAA P10253 1/20 0.45
TSHR P16473 2/20 0.43
POLB P06746 2/20 0.42
USP2 O75604 2/20 0.42
GRIA3 P42263 1/20 0.40
GRIA4 P48058 1/20 0.40
HPGD P15428 2/20 0.38
HSD17B10 Q99714 2/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL562770 0.75 ALDH1A1 (0.68) ALDH1A1KMT2AMEN1MAPTHTT
SCHEMBL3129599 0.74 ALDH1A1 (0.72) ALDH1A1KMT2AMEN1MAPTHTT
SCHEMBL3123679 0.70 ALDH1A1 (0.70) ALDH1A1KMT2AMEN1MAPTHTT
SCHEMBL3119482 0.69 ALDH1A1 (0.71) ALDH1A1KMT2AMEN1MAPTHTT
SCHEMBL4084506 0.69 ALDH1A1 (0.67) ALDH1A1KMT2AMEN1MAPTHTT
SCHEMBL563216 0.67 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTHTT
SCHEMBL562289 0.66 ALDH1A1 (0.61) ALDH1A1KMT2AMEN1MAPTHTT
SCHEMBL562822 0.65 MYB (0.61) ALDH1A1KMT2AMEN1MAPTHTT
SCHEMBL28162015 0.64 GAA (1.00) ALDH1A1KMT2AMEN1MAPTHTT
SCHEMBL6705768 0.64 ALDH1A1 (0.78) ALDH1A1KMT2AMEN1MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138356-B2 Chemical inhibitors of inhibitors of differentiation Angiogeney, Inc. (US) 2012-03-20 US disclosed
US-20090226422-A1 Chemical Inhibitors of Inhibitors of Differentiation ANGIOGENEX 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090226422-A1 Chemical Inhibitors of Inhibitors of Differentiation BRAF, MAPK1, RAF1 ALDH1A1 1860/4885KMT2A 3273/4885MEN1 3968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.